KRASHIA, PARASKEVI
 Distribuzione geografica
Continente #
AS - Asia 1.956
NA - Nord America 254
EU - Europa 177
AF - Africa 5
SA - Sud America 3
OC - Oceania 1
Totale 2.396
Nazione #
SG - Singapore 1.741
US - Stati Uniti d'America 244
CN - Cina 117
IT - Italia 83
HK - Hong Kong 81
GB - Regno Unito 38
DE - Germania 17
NL - Olanda 15
IN - India 8
CA - Canada 7
FI - Finlandia 6
UA - Ucraina 4
ZA - Sudafrica 4
FR - Francia 3
PL - Polonia 3
AT - Austria 2
BR - Brasile 2
JP - Giappone 2
MX - Messico 2
PK - Pakistan 2
CL - Cile 1
DZ - Algeria 1
GR - Grecia 1
IE - Irlanda 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MY - Malesia 1
NR - Nauru 1
PH - Filippine 1
SA - Arabia Saudita 1
SE - Svezia 1
TR - Turchia 1
Totale 2.396
Città #
Singapore 86
Hong Kong 80
Hefei 50
Ashburn 42
Rome 39
Boardman 36
London 33
Milan 29
Santa Clara 26
Beijing 22
Shanghai 19
Council Bluffs 18
Los Angeles 12
Buffalo 10
Dallas 10
Amsterdam 9
Munich 7
San Francisco 5
Secaucus 5
Turku 5
Brooklyn 4
Pune 4
Cave 3
Charlotte 3
Chennai 3
Johannesburg 3
Roubaix 3
Toronto 3
Warsaw 3
Washington 3
Hanover 2
Manchester 2
Mexico City 2
Montreal 2
Nanjing 2
New York 2
Redmond 2
Seattle 2
The Dalles 2
Tokyo 2
Xi'an 2
Yangzhou 2
Almere Stad 1
Atlanta 1
Bagheria 1
Bagnaria Arsa 1
Berlin 1
Boufarik 1
Bradford 1
Cagliari 1
Castries 1
Central 1
Changchun 1
Colombo 1
Denver 1
Dublin 1
Frankfurt am Main 1
Guangzhou 1
Hamburg 1
Helsinki 1
Heraklion 1
Kuala Lumpur 1
Luxembourg 1
Milwaukee 1
Mumbai 1
Nanning 1
Nuremberg 1
Oliveira 1
Phoenix 1
Providence 1
Queens 1
Quezon City 1
Riga 1
Riyadh 1
St Louis 1
Stockholm 1
São Paulo 1
Vancouver 1
Waldshut-Tiengen 1
Yaren District 1
Totale 637
Nome #
Author Correction: Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease (Nature Communications, (2019), 10, 1, (3945), 10.1038/s41467-019-11928-w) 198
Chemogenetic rectification of the inhibitory tone onto hippocampal neurons reverts autistic-like traits and normalizes local expression of estrogen receptors in the Ambra1+/- mouse model of female autism 196
Incorporation of the β3 subunit has a dominant-negative effect on the function of recombinant central-type neuronal nicotinic receptors 189
Cisd2: a promising new target in Alzheimer's disease† 185
Hippocampal epileptogenesis in autoimmune encephalitis. 166
Passive immunotherapy for N-truncated tau ameliorates the cognitive deficits in two mouse Alzheimer's disease models 156
How dopamine tunes parvalbumin interneurons in the hippocampus: new experimental observations in Alzheimer's disease 127
Dopamine neuron degeneration in the Ventral Tegmental Area causes hippocampal hyperexcitability in experimental Alzheimer’s Disease 113
Dysfunctional dopaminergic neurotransmission in asocial BTBR mice 103
Ambra1 shapes hippocampal inhibition/excitation balance: role in neurodevelopmental disorders 90
Neurodevelopmental Disorders: Functional Role of Ambra1 in Autism and Schizophrenia. 90
Human α3β4 neuronal nicotinic receptors show different stoichiometry if they are expressed in Xenopus oocytes or mammalian HEK293 cells 88
Agonist and blocking actions of choline and tetramethylammonium on human muscle acetylcholine receptors 85
Persistent elevation of D-Aspartate enhances NMDA receptor-mediated responses in mouse substantia nigra pars compacta dopamine neurons. 85
The VTA dopaminergic system as diagnostic and therapeutical target for Alzheimer's disease 80
Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease 71
Early derailment of firing properties in CA1 pyramidal cells of the ventral hippocampus in an Alzheimer's disease mouse model 69
Nilotinib restores memory function by preventing dopaminergic neuron degeneration in a mouse model of Alzheimer's Disease 53
Dopamine loss alters the hippocampus-nucleus accumbens synaptic transmission in the Tg2576 mouse model of Alzheimer's disease 53
Upregulation of Ca2+-binding proteins contributes to VTA dopamine neuron survival in the early phases of Alzheimer's disease in Tg2576 mice 45
The role of dopamine in NLRP3 inflammasome inhibition: Implications for neurodegenerative diseases 38
Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer's disease 34
Transcranial alternating current stimulation (tACS) at gamma frequency: an up-and-coming tool to modify the progression of Alzheimer’s Disease 30
On the properties of identified dopaminergic neurons in the mouse substantia nigra and ventral tegmental area. 27
Unifying Hypothesis of Dopamine Neuron Loss in Neurodegenerative Diseases: Focusing on Alzheimer's Disease. 26
The long activations of α2 glycine channels can be described by a mechanism with reaction intermediates ("flip") 25
Totale 2.422
Categoria #
all - tutte 11.751
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.751


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202230 0 0 0 0 0 0 1 8 2 0 0 19
2022/202379 0 0 54 3 3 0 0 0 1 0 18 0
2023/202490 4 11 6 12 5 44 0 0 4 2 0 2
2024/20252.017 29 6 45 10 21 42 17 31 55 138 697 926
2025/2026206 108 47 10 41 0 0 0 0 0 0 0 0
Totale 2.422